Welcome to LookChem.com Sign In|Join Free
  • or
1,3-Dioxane, 2-(3-chloropropyl)-2-(4-fluorophenyl)-5,5-dimethyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

36714-65-5

Post Buying Request

36714-65-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

36714-65-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 36714-65-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,7,1 and 4 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 36714-65:
(7*3)+(6*6)+(5*7)+(4*1)+(3*4)+(2*6)+(1*5)=125
125 % 10 = 5
So 36714-65-5 is a valid CAS Registry Number.

36714-65-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(3-chloropropyl)-2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxane

1.2 Other means of identification

Product number -
Other names 2-(4-fluorophenyl)-2-(3-chloropropyl)-5,5-dimethyl-1,3-dioxane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:36714-65-5 SDS

36714-65-5Relevant academic research and scientific papers

NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES

-

Paragraph 164, (2017/03/21)

The present invention provides novel means and methods for treatment auf immunemediated inflammatory diseases.

NR2B-SELECTIVE NMDA-RECEPTOR ANTAGONISTS

-

Page/Page column 48, (2010/11/05)

The present invention relates to compounds according to general formula (I) and pharmaceutical compositions comprising compounds according to general formula (I).

Design, synthesis, and biological evaluation of 3-benzazepin-1-ols as NR2B-selective NMDA receptor antagonists

Tewes, Bastian,Frehland, Bastian,Schepmann, Dirk,Schmidtke, Kai-Uwe,Winckler, Thomas,Wuensch, Bernhard

scheme or table, p. 687 - 695 (2010/12/29)

Cleavage and reconstitution of a bond in the piperidine ring of ifenprodil (1) leads to 7-methoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-1-ols, a novel class of NR2B-selective NMDA receptor antagonists. The secondary amine 7-methoxy-2,3,4,5-tetrahydro-1H-3-be

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 36714-65-5